Dr. John Joseph Byrnes, MD

Dr. Byrnes practices at Jackson Memorial Hospital in Miami, Florida, part of Miami-Dade County.

Dr. Byrnes' NPI, 1780635235, was assigned on May 12, 2006. Dr. Byrnes graduated from Tufts University School Of Medicine in 1968. Dr. Byrnes holds Florida license ME0019219.

Dr. Byrnes' primary practice is Jackson Memorial Hospital, at 1611 Nw 12th Ave, Miami, FL 33136 in Miami-Dade County. The practice phone is (305) 585-1111.

Dr. Byrnes' primary practice is Jackson Memorial Hospital in Miami, Florida, part of Miami-Dade County. Dr. Byrnes is also affiliated with Sylvester Comprehensive Cancer Center. The medical group on file is University of Miami Health System.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Byrnes practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Byrnes' primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Byrnes is board certified in diagnostic laboratory immunology by the American Board of Internal Medicine. Dmand AI has Dr. Byrnes' licenses on file in 2 states: Florida and Maryland.

Dmand AI lists chronic anemia, colorectal cancer, lung cancer, lymphoma, multiple myeloma, neutropenia and prostate cancer among the conditions Dr. Byrnes treats.

CMS data shows 233 Medicare services from Dr. Byrnes across 3 procedure codes in 2024, for 102 Medicare patients. Medicare paid $19,367 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 102 Medicare patients who saw Dr. Byrnes in 2024. The largest group is 65 to 74, with 33 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 55% are also on Medicaid. Their average risk score is 3.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Byrnes' median patient age at 64, with 53% women.

In 2021, Dr. Byrnes wrote 36 Medicare Part D claims. They cover 3 drugs, with $248,189 in total drug cost. In 2020, CMS named 60 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Byrnes for performance year 2024, reported as part of a group. Dr. Byrnes accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 49 papers to Dr. Byrnes, published from 2007 to 2021. 2009 was the busiest year, with 2. The most frequent topics are Rabbits, Bone Marrow and Kinetics. Dr. Byrnes has published most often in Biochemistry. Dr. Byrnes' most frequent co-authors are Joshua M. Hare, FACC, MD, Maureen H. Lowery, MD and Alan W. Heldman, MD.

CMS Open Payments shows 111 general payments to Dr. Byrnes from 21 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 43% of the total. Janssen Pharmaceuticals, Inc paid the most, $3,711.

Dmand AI lists 2 awards for Dr. Byrnes, most recently CMS Stage 1 EHR in 2013.

Dr. Byrnes graduated from Tufts University School Of Medicine in 1968.

Dr. Byrnes is in network with 8 carriers, including Elevance, United Healthcare and Molina. Medicare plans come from the most carriers, 4. Check the plan with the practice before a visit.